Richard E Stiles, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 18501 Nw Montreux Dr, Issaquah, WA 98027 Phone: 425-373-9226 |
News Archive
Social competence and behavior problems that are evident at kindergarten and first grade are known to be strong predictors of a child's academic and social functioning. However, findings reported in the July issue of the Journal of the American Academy of Child and Adolescent Psychiatry suggest that psychosocial risk factors can be identified even earlier and can be observed during the transition from preschool to formal schooling.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
Blindness is often caused by corneal diseases. The established treatment is a corneal transplant, but in many cases this is not possible and donor corneas are often hard to come by. In the future, an artificial cornea could make up for this deficiency and save the vision of those affected.
In a shift away from the more patriarchal/matriarchal relationship between doctor and patient, patients report an increased partnership with their physicians in making medical decisions, reports a new study from Northwestern Medicine and Harvard University.
The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.
› Verified 6 days ago